177Lu-ITM-51

N/A

Report date: 2025/11/12 17:54:44

Base Information

Drug Name177Lu-ITM-51

Drug Alias NameITM-51

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionIonising radiation emitters

TargetsFolate receptor alpha

Therapy Area/IndicationsOvarian NeoplasmsAdenocarcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesITM Radiopharmazie Munchen GmbH

China Registration ClassN/A

Develop Information

Active CompaniesITM Radiopharmazie Munchen GmbH

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsAdenocarcinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A